S. Kurtin

950 total citations · 1 hit paper
8 papers, 674 citations indexed

About

S. Kurtin is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, S. Kurtin has authored 8 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 2 papers in Molecular Biology and 1 paper in Genetics. Recurrent topics in S. Kurtin's work include Acute Myeloid Leukemia Research (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). S. Kurtin is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). S. Kurtin collaborates with scholars based in United States. S. Kurtin's co-authors include Alan F. List, Robert Knight, Daruka Mahadevan, Lisa M. Rimsza, Jerome B. Zeldis, Deborah Fuchs, Denise J. Roe, Ruth Heaton, Glen J. Weiss and Daruka Mahadevan and has published in prestigious journals such as New England Journal of Medicine, Leukemia Research and American Journal of Clinical Oncology.

In The Last Decade

S. Kurtin

6 papers receiving 653 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of Lenalidomide in Myelodysplastic Syndromes

2005 613 citations Alan F. List, S. Kurtin et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Kurtin United States	3	554	280	250	77	71	8	674
Ruth Heaton United States	5	684 1.2×	337 1.2×	284 1.1×	108 1.4×	79 1.1×	8	847
Emiliano Fabiani Italy	18	444 0.8×	419 1.5×	184 0.7×	101 1.3×	42 0.6×	48	695
Lisa Hopcroft United Kingdom	13	489 0.9×	342 1.2×	293 1.2×	141 1.8×	35 0.5×	23	814
Michele Cedrone Italy	16	375 0.7×	296 1.1×	237 0.9×	85 1.1×	25 0.4×	36	620
Andrew Kuykendall United States	14	621 1.1×	385 1.4×	512 2.0×	136 1.8×	28 0.4×	174	839
Olga Salamero Spain	13	625 1.1×	381 1.4×	282 1.1×	167 2.2×	143 2.0×	46	890
Agata Wrzesień‐Kuś Poland	14	365 0.7×	280 1.0×	147 0.6×	126 1.6×	24 0.3×	22	606
Giambattista Bertani Italy	8	302 0.5×	188 0.7×	103 0.4×	70 0.9×	42 0.6×	20	460
Anna Grazia Recchia Italy	16	302 0.5×	265 0.9×	151 0.6×	166 2.2×	96 1.4×	38	653
Fabio P S Santos United States	10	374 0.7×	171 0.6×	203 0.8×	99 1.3×	39 0.5×	16	520

Countries citing papers authored by S. Kurtin

Since Specialization

Citations

This map shows the geographic impact of S. Kurtin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Kurtin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Kurtin more than expected).

Fields of papers citing papers by S. Kurtin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Kurtin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Kurtin. The network helps show where S. Kurtin may publish in the future.

Co-authorship network of co-authors of S. Kurtin

This figure shows the co-authorship network connecting the top 25 collaborators of S. Kurtin. A scholar is included among the top collaborators of S. Kurtin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Kurtin. S. Kurtin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Kurtin, S., et al.. (2017). Pilot Testing of a Health and Life Management Mobile Health Application for Caregivers and Patients Living with Myelodysplastic Syndromes. Leukemia Research. 55. S129–S129. 2 indexed citations

2.

Kurtin, S., et al.. (2015). 7 SYMPTOM BURDEN AND QUALITY OF LIFE AMONG PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS): ANALYSIS OF SURVEY DATA. Leukemia Research. 39. S3–S3. 1 indexed citations

3.

Mahadevan, Daruka, Pavani Chalasani, S. Kurtin, et al.. (2012). Phase I Trial of AEG35156 an Antisense Oligonucleotide to XIAP Plus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma. American Journal of Clinical Oncology. 36(3). 239–243. 35 indexed citations

4.

Kurtin, S.. (2011). 22 Risk analysis in the treatment of myelodysplastic syndromes in the elderly. Leukemia Research. 35. S8–S9.

5.

Demakos, Erin P. & S. Kurtin. (2011). 354 Disease burden and treatment impact associated with myelodysplastic syndromes: Initial estimates. Leukemia Research. 35. S142–S142.

6.

Mahadevan, Daruka, et al.. (2009). Phase I Study of Fixed Dose Gemcitabine Plus Epirubicin in Patients With Advanced Solid Malignancies. American Journal of Clinical Oncology. 32(6). 607–611. 2 indexed citations

7.

List, Alan F., Kenton Wride, G.W. Dewald, et al.. (2007). C028 Cytogenetic response to lenalidomide is associated with improved survival in patients with chromosome 5q deletion. Leukemia Research. 31. S38–S38. 21 indexed citations

8.

List, Alan F., S. Kurtin, Denise J. Roe, et al.. (2005). Efficacy of Lenalidomide in Myelodysplastic Syndromes. New England Journal of Medicine. 352(6). 549–557. 613 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact